Status:
UNKNOWN
The Efficacy and Safety of Cettum for Perennial Allergic Rhinitis
Lead Sponsor:
Eun Jung Kim
Collaborating Sponsors:
DongGuk University
Conditions:
Rhinitis, Allergic
Eligibility:
All Genders
19-60 years
Phase:
NA
Brief Summary
The purpose of this study is verify the efficacy and safety of Cettum (Electrical moxibustion) for patients with perennial allergic rhinitis.
Detailed Description
The investigators target the patients with perennial allergic rhinitis. After treatment in 2 groups (Cettum treatment and acupuncture treatment) the investigators will compare the effects of relieving...
Eligibility Criteria
Inclusion
- 19 to 60 years-old
- Presence of nasal symptoms more than 2 consecutive years
- Presence of two or more nasal symptoms (rhinorrhea, nasal congestion, nasal itching, and sneezing) with severity score ≥ 2 (0 = no symptoms, 1 = mild symptom(s), 2 = moderate symptom(s), and 3 = severe symptom(s))
- Positive reaction to the one or more perennial allergen in skin prick test
- Not having a problem with expression of opinion
- Willingness to participate in this trial and to sign the informed consent agreement
Exclusion
- Treatment with nasal/oral corticosteroids within the past month; herbal medication for rhinitis within the past month; nasal cromolyn or tricyclic antidepressants within the past two weeks; nasal/oral decongestants, nasal/oral antihistamines, or antileukotrienes within the past week
- Presence of rhinosinusitis (paranasal sinus X-ray demonstrating mucosal thickening or opacification of the paranasal sinuses)
- Presence of neoplasm, severe systemic inflammation, or other systemic disease that affects rhinitis
- History of anaphylaxis for allergic tests
- Females who is pregnant or lactating
- Being difficult to maintain treatment (e.g. paralysis, severe physical or psychiatric disorder, dementia, drug intoxication, severe visual or hearing impairment)
- Being afraid of moxibustion treatment or expected adverse effects
- When the investigators determine that it is inappropriate for participation
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03342105
Start Date
December 1 2017
End Date
December 1 2018
Last Update
November 14 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.